PMID- 35326535 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220329 IS - 2072-6694 (Print) IS - 2072-6694 (Electronic) IS - 2072-6694 (Linking) VI - 14 IP - 6 DP - 2022 Mar 8 TI - Occurrence of Total and Proteinase K-Resistant Alpha-Synuclein in Glioblastoma Cells Depends on mTOR Activity. LID - 10.3390/cancers14061382 [doi] LID - 1382 AB - Alpha-synuclein (alpha-syn) is a protein considered to be detrimental in a number of degenerative disorders (synucleinopathies) of which alpha-syn aggregates are considered a pathological hallmark. The clearance of alpha-syn strongly depends on autophagy, which can be stimulated by inhibiting the mechanistic target of rapamycin (mTOR). Thus, the overexpression of mTOR and severe autophagy suppression may produce alpha-syn accumulation, including the proteinase K-resistant protein isoform. Glioblastoma multiforme (GBM) is a lethal brain tumor that features mTOR overexpression and severe autophagy inhibition. Cell pathology in GBM is reminiscent of a fast, progressive degenerative disorder. Therefore, the present work questions whether, as is analogous to neurons during degenerative disorders, an overexpression of alpha-syn occurs within GBM cells. A high amount of alpha-syn was documented in GBM cells via real-time PCR (RT-PCR), Western blotting, immunohistochemistry, immuno-fluorescence, and ultrastructural stoichiometry, compared with the amount of beta- and gamma-synucleins and compared with the amount of alpha-syn counted within astrocytes. The present study indicates that (i) alpha-syn is overexpressed in GBM cells, (ii) alpha-syn expression includes a proteinase-K resistant isoform, (iii) alpha-syn is dispersed from autophagy-like vacuoles to the cytosol, (iv) alpha-syn overexpression and cytosol dispersion are mitigated by rapamycin, and (v) the alpha-syn-related GBM-like phenotype is mitigated by silencing the SNCA gene. FAU - Ryskalin, Larisa AU - Ryskalin L AUID- ORCID: 0000-0003-3150-1863 AD - Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126 Pisa, Italy. FAU - Ferese, Rosangela AU - Ferese R AD - Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Neuromed, Via Atinense 18, 86077 Pozzilli, Italy. FAU - Morucci, Gabriele AU - Morucci G AUID- ORCID: 0000-0003-0518-2184 AD - Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126 Pisa, Italy. FAU - Biagioni, Francesca AU - Biagioni F AUID- ORCID: 0000-0003-3566-4889 AD - Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Neuromed, Via Atinense 18, 86077 Pozzilli, Italy. FAU - Busceti, Carla L AU - Busceti CL AD - Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Neuromed, Via Atinense 18, 86077 Pozzilli, Italy. FAU - Michetti, Fabrizio AU - Michetti F AUID- ORCID: 0000-0003-2546-0532 AD - Departmentof Neuroscience, Universita Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy. AD - IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) San Raffaele Scientific Institute, Universita Vita-Salute San Raffaele, Via Olgettina 6, 20121 Milan, Italy. FAU - Lenzi, Paola AU - Lenzi P AUID- ORCID: 0000-0002-4734-8798 AD - Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126 Pisa, Italy. FAU - Frati, Alessandro AU - Frati A AD - Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Neuromed, Via Atinense 18, 86077 Pozzilli, Italy. AD - Neurosurgery Division, Human Neurosciences Department, Sapienza University, 00135 Roma, Italy. FAU - Fornai, Francesco AU - Fornai F AUID- ORCID: 0000-0002-3883-5084 AD - Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126 Pisa, Italy. AD - Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Neuromed, Via Atinense 18, 86077 Pozzilli, Italy. LA - eng GR - Ricerca Corrente 2021/Ministero della Salute/ PT - Journal Article DEP - 20220308 PL - Switzerland TA - Cancers (Basel) JT - Cancers JID - 101526829 PMC - PMC8946689 OTO - NOTNLM OT - autophagy vacuoles OT - cell-clearing systems OT - glioblastoma multiforme OT - mechanistic target of rapamycin OT - qRT-PCR OT - siRNA OT - synucleins OT - transmission electron microscopy COIS- The authors declare no conflict of interest. EDAT- 2022/03/26 06:00 MHDA- 2022/03/26 06:01 PMCR- 2022/03/08 CRDT- 2022/03/25 01:01 PHST- 2022/01/11 00:00 [received] PHST- 2022/03/01 00:00 [revised] PHST- 2022/03/07 00:00 [accepted] PHST- 2022/03/25 01:01 [entrez] PHST- 2022/03/26 06:00 [pubmed] PHST- 2022/03/26 06:01 [medline] PHST- 2022/03/08 00:00 [pmc-release] AID - cancers14061382 [pii] AID - cancers-14-01382 [pii] AID - 10.3390/cancers14061382 [doi] PST - epublish SO - Cancers (Basel). 2022 Mar 8;14(6):1382. doi: 10.3390/cancers14061382.